We examine how CMS F841 and new OIG oversight raise expectations for nursing home medical directors, demanding visible engagement, better policies, and data-informed leadership. We share field lessons on antipsychotics, facility assessment, and building dashboards that support real accountability.
• CMS shifts from F501 to F841 and clarifies medical director duties
• OIG focus on engagement, visit frequency, and compensation integrity
• Risks of absent or passive medical directors in daily care
• Antipsychotics oversight, diagnostic accuracy, and documentation alignment
• Hands-on leadership beyond QAPI with nursing and administration
• Facility assessment that reflects the real resident mix and needs
• Data and AI dashboards to drive timely, targeted action
• Contracts, coverage, and accountability that sustain engagement
We examine how the federal shutdown disrupts nursing home oversight, why CMS triaged surveys to emergencies, and the risks created by fewer inspectors and furloughed staff. We share steps facilities can take to protect residents, drawing lessons from the OIG’s pandemic report. • status of…
